In the early and mid-1980s, scientists used phages to express recombinant proteins. The protein was retained inside the virions, so screening required growing viral plaques, creating a stamp of these ...
Phage display research is advancing rapidly. Creative Biolabs supports this momentum with cutting‑edge platforms designed to address emerging challenges in binder discovery and screening.
Researchers have mapped out what a commonly-used form of phage looks like, which will help design better uses in future. New insights into the structure of phages will enable researchers to develop ...
Co announces that they have licensed their antibody phage display libraries to Cambridge Antibody Technology, a wholly-owned subsidiary of AstraZeneca (AZN), for the discovery of therapeutic ...
News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results